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2 
Abstract 22 
Bluetongue (BT) is a climate change-related emerging infectious disease in Europe. 23 
Outbreaks of serotypes 1, 2, 4, 6, 8, 9, 11, and 16 are challenging Central and Western 24 
Europe since 1998. Measures to control or eradicate bluetongue virus (BTV) from 25 
Europe have been implemented, including movement restrictions and vaccination of 26 
domestic BTV-susceptible ruminants. However, these measures are difficult to apply in 27 
wild free-ranging hosts of the virus, like red deer (Cervus elaphus), which could play a 28 
role in the still unclear epidemiology of BT in Europe. We show for the first time that 29 
BTV RNA can be detected in European red deer blood for long periods, comparable to 30 
those of domestic ruminants, after experimental infection with BTV-1 and BTV-8. BTV 31 
RNA was detected in experimentally-infected red deer blood up to the end of the study 32 
(98-112 dpi). BTV-specific antibodies were found in serum both by enzyme-linked 33 
immunosorbent assay (ELISA) and virus neutralization (VNT) from 8-12 dpi to the end 34 
of the study, peaking at 17-28 dpi. Our results indicate that red deer can be infected with 35 
BTV and maintain BTV RNA for long periods, remaining essentially asymptomatic. 36 
Thus, unvaccinated red deer populations have the potential to be a BT reservoir in 37 
Europe, and could threaten the success of the European BTV control strategy. 38 
Therefore, wild and farmed red deer should be taken into account for BTV surveillance, 39 
and movement restrictions and vaccination schemes applied to domestic animals should 40 
be adapted to include farmed or translocated red deer. 41 
 42 
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 3 
1. Introduction 43 
 44 
Formerly considered an exotic viral disease of wild and domestic ruminants, 45 
several outbreaks of bluetongue (BT) virus serotypes 1, 2, 4, 6, 8, 9, 11, and 16 have 46 
challenged Europe since 1998. BT is an emerging infectious disease related to climate 47 
change (Purse et al., 2005; Breard et al., 2007; Enserink, 2008; Rodríguez-Sánchez et 48 
al., 2008; Eschbaumer et al., 2009; European Commission, 2009). 49 
Measures to control bluetongue virus (BTV) in Europe include movement 50 
restrictions and vaccination (European Commission, 2009), and surveillance systems for 51 
BT are being established (Hadorn et al., 2009). As of May 2009, the largest restriction 52 
zones in Europe correspond to BTV serotypes 1 (BTV-1), which is expanding 53 
northwards since its first introduction in Southern Spain in 2007, and 8 (BTV-8), 54 
spreading throughout Europe since it appeared in The Netherlands in 2006 (Purse et al., 55 
2005; Rodríguez-Sánchez et al., 2008). The target of the vaccination campaign is to 56 
achieve at least 80% coverage of domestic ruminants using killed vaccines, although 57 
doubts have arisen about its effectiveness (Enserink, 2008; Rodríguez-Sánchez et al., 58 
2008). 59 
Red deer (Cervus elaphus) population density in Europe ranges from 2 to 30 60 
individuals per square kilometre (up to 70 for food supplemented populations) 61 
(Acevedo et al., 2008; Lovari et al., 2009), which could account for a significant 62 
percentage of the BTV-infection susceptible ruminant population in certain regions.  63 
  Wild ruminants are included in the European Council Directive 2000/75/EC of 64 
20 November 2000, laying down specific provisions for the control and eradication of 65 
bluetongue, but vaccination and movement restrictions can only be applied in farmed or 66 
managed ruminants, being almost impossible in wild free-ranging hosts of the virus. 67 
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 4 
High prevalence of serum antibodies against BTV has been reported in several species 68 
of wild ungulates, including red deer (Linden et al. 2008; Ruiz-Fons et al. 2008; García 69 
et al. 2009), suggesting widespread contact of wild ruminants with BTV. Moreover, 70 
BTV RNA has been recently detected in farmed red deer in Spain (serotypes 1 and 4) 71 
(Rodríguez-Sánchez et al. 2010) but BTV infection seems not to result in a significant 72 
mortality in red deer (Linden et al. 2008), although sporadic fatal disease with BTV 73 
isolation has been reported in mouflon (Ovis aries) (Fernández-Pacheco et al. 2008). BT 74 
is considered endemic in wild ruminants in parts of Africa and North America 75 
(Stallknecht et al. 1996; Gerdes, 2004), but up to now little is known about the role deer 76 
could play in the epidemiology of BT in Europe. The aim of this study is to determine 77 
the dynamics of BTV serotypes 1 and 8 infection in red deer, thus assessing the 78 
potential of this species as a wild reservoir for BT. 79 
 80 
2. Materials and methods 81 
 82 
Eleven seven month-old red deer females were transported into the insect-proof 83 
biosecurity level 3 (BSL3) facilities of the Centro de Investigación en Sanidad Animal 84 
(CISA) in Valdeolmos (Madrid) on January 19
th
 2009. The deer were kept in three 85 
different boxes (four in boxes A and B and three in box C). According to the routine 86 
BSL3 procedures, each box was isolated from the others, sampling material was 87 
exclusively used in the same box and the operators changed clothes before and after 88 
working in a box, having a shower to exit from each box. One week after arriving to the 89 
CISA, four of the deer (deer 1 to deer 3 in box A and deer 4 in box C) were inoculated 90 
intravenously (iv) with 2,5x10
6
 TCID50 of BTV-1 strain Algeria/2006. This strain was 91 
received from the Institue for Animal Health in Pirbright, and underwent five cell 92 
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 5 
culture passages prior to inoculation. Other four deer (deer 5 to deer 7 in box B and deer 93 
8 in box C) were inoculated iv with 2,5x10
6
 TCID50 BTV-8 isolate 202326 94 
(Belgium/2006). This strain was received from the Istituto Zooprofilattico Sperimentale 95 
Della Lombardia e dell’Emilia Romagna (IZSLER), and was inoculated after four 96 
culture passages. Finally, the three remaining deer (deer 9 in box A, deer 10 in box B, 97 
and deer 11 in box C) received iv an equivalent volume of cell culture medium, acting 98 
as controls. The deer were monitored daily from 0 days post-infection (dpi) to 12 dpi 99 
and on 14, 17, 21, 24, 28, 31, 38, 50, 60, 66, 71, and 78 dpi. Monitoring included 100 
exploration for clinical signs of bluetongue (rectal temperature, facial oedema, 101 
erythema, coronitis, stomatitis, conjunctivitis), as well as collection of blood samples 102 
with anticoagulant for real time RT-PCR analysis and without anticoagulant for serum. 103 
Skin biopsies were taken at 14 dpi from the eight deer at boxes A and B (three BTV-1 104 
inoculated, three BTV-8 inoculated and two controls). The deer were euthanized on 98 105 
(four deer at box B), 105 (four deer at box A), and 112 dpi (three deer at box C). 106 
Viral BTV RNA in blood was assessed using a modification of an already described 107 
semi-quantitative real-time RT-PCR (Toussaint et al., 2007). Serum antibodies were 108 
analyzed by commercial ELISA (Pourquier Bluetongue competitive ELISA, Institut 109 
Pourquier, Montpellier, France), and by standard virus neutralization test (VNT) using 110 
the inoculation virus as antigen, similarly to the methodology previously reported 111 
(Hamers et al., 2009). Virus isolation was attempted in Vero and BHK cells only at 112 
peak genome detection (12 dpi) and at late stagesof the infection (78 dpi) one BTV-1 113 
(deer 4) and one BTV-8 (deer 7) inoculated deer. 114 
This study was approved by the INIA Ethics Committees on Animal 115 
Experimentation and Biosafety. Handling procedures and sampling frequency were 116 
designed to reduce stress and health risks for subjects, according to European (86/609) 117 
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and Spanish laws (R. D. 223/1988, R. D. 1021/2005), and current guidelines for ethical 118 
use of animals in research (ASAB, 2006). 119 
 120 
3. Results 121 
 122 
BTV RNA was detected in all deer inoculated with BTV-1 (deer 1 to 4) and 123 
three out of the four deer inoculated with BTV-8 (deer 5 to 7) from one dpi to the end of 124 
the study, with a peak around twelve dpi for both serotypes, and a slow decline 125 
thereafter. Figure 1 shows dynamics of BTV RNA detected in blood of the infected red 126 
deer, as assessed by real-time RT-PCR. Detection of BTV RNA was low and transient 127 
for BTV-8-infected deer 8 (box C), disappearing after 14 dpi. No virus RNA was 128 
detected in none of the control deer until 38 dpi. However, on 38 dpi BTV RNA was 129 
detected in control deer 11 (box C), followed by seroconversion between 38 and 50 dpi. 130 
The virus infecting this deer was characterized as BTV-1 both by VNT and BTV-131 
1/BTV-8 multiplex real-time RT-PCR (Fernández-Pinero et al., in prep.). From all the 132 
four samples where BTV isolation was tried, only BTV-1 was recovered at 12 dpi from 133 
deer 4 (inoculated with BTV-1) in Vero cells. Only mild transient unspecific clinical 134 
signs, which could be compatible with BT, were observed in the infected deer, and no 135 
statistically significant difference, peak or trend in rectal temperature was evidenced.  136 
Serum antibodies against BTV were detected in all inoculated deer both by VNT 137 
and ELISA tests. ELISA revealed BTV specific antibodies by 10 dpi in the BTV-1 138 
group, and between 9 and 12 dpi in the BTV-8 group, antibodies being present 139 
throughout the whole study period for both serotypes. In deer inoculated with BTV-1, 140 
the neutralizing antibody response was first detected at 8-11 dpi, with peak titres of 141 
1/1280 around 17-21 dpi. In deer inoculated with BTV-8 neutralizing antibodies 142 
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 7 
appeared at 8 dpi, with peak titres of 1/640 to 1/1280 between 17 and 28 dpi. Controls 9 143 
and 10 showed no specific antibodies throughout the whole experiment. However, 144 
control deer 11, the one where BTV RNA was first detected at 38 dpi, seroconverted by 145 
45 dpi, showing antibodies against BTV-1 until the end of the study (Figure 2). 146 
BTV RNA was detected in the skin biopsies obtained at 14 dpi in five out of the 147 
six BTV-inoculated deer (three inoculated with BTV-1 and two with BTV-8) analyzed. 148 
The result was doubtful for the remaining BTV-8-inoculated deer, and negative for the 149 
two control deer sampled.  150 
  151 
4. Discussion 152 
 153 
Our results confirm that Iberian red deer get asymptomatically infected with 154 
BTV serotypes 1 and 8, BTV RNA being reliably detected for long periods, comparable 155 
in intensity and duration to that of domestic ungulates
 
(Luedke, 1969; MacLachlan et al. 156 
1990; Puentes et al., 2008). RT-PCR has been validated as a detection technique for 157 
BTV, at least as sensitive as viral titration on Vero cells (Hamers et al. 2009). BTV 158 
viraemia with mild or no clinical signs following experimental infection has been 159 
reported in North American elk (Cervus elaphus canadensis and Cervus elaphus 160 
nelsoni) (Murray and Trainer, 1990; Ellis et al., 1993). BTV was isolated as long as 105 161 
dpi from the blood of experimentally infected elk after 95 days of negative results 162 
followed by cortisone injection (Murray and Trainer 1970). However, duration and 163 
intensity of both the virus dynamics and the immune response remains to be fully 164 
described. To the best of our knowledge, this is the first report to address this issue in 165 
European red deer. The kinetics of the antibody response of our experimentally-infected 166 
red deer during the study period was similar to those of experimentally infected 167 
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domestic ruminants and North American elk (Murray and Trainer, 1970), showing the 168 
validity of ELISA and serum VNT to monitor contact with BTV in red deer. The 169 
clinical picture observed among BTV-1 and BTV-8 infected deer was similar to the 170 
mild subclinical effects of BTV observed in cattle (MacLachlan et al., 1990) and elk 171 
(Murray and Trainer, 1970; Ellis et al., 1993), rather than to the more severe clinical 172 
pictures often described in sheep (MacLachlan et al., 2008) and white-tailed deer 173 
(Vosdingh et al., 1968). 174 
Transplacental, oral, and wound contact have been suggested as mechanisms for 175 
BTV transmission in absence of the Culicoides vector, both in domestic and wild 176 
ungulates (Vosdingh et al. 1968; Thomas and Trainer, 1970; Menzies et al., 2008; 177 
Backx et al., 2009). Iatrogenic transmission can be discarded for the spontaneously-178 
infected control deer 11 of our study, since material for each deer was prepared 179 
individually before entering the enclosure, so oral (the deer bit each other due to 180 
hierarchic fights in the small area of the enclosure) or wound transmission would be the 181 
most likely explanation. Transmission in absence of the vector is therefore possible in 182 
close contact conditions, and although its epidemiological importance is unknown, it 183 
could be a concern regarding the overwintering of BTV (Wilson et al., 2008).   184 
Which is the role of red deer in the epidemiology of BTV in Europe? Red deer is 185 
an abundant wild ruminant in many parts of the northern hemisphere, occurring in BTV 186 
affected regions of central and southern Europe (Lovari et al., 2009). Other wild 187 
ruminant species are considered maintenance hosts for BTV in Africa and North 188 
America, the virus being endemic in their populations (Stallknecht et al., 1996; Gerdes, 189 
2004). Antibodies against BTV and BTV RNA have been identified in free-ranging 190 
naturally infected red deer in Europe (Linden et al., 2008; Ruiz-Fons et al., 2008; García 191 
et al., 2009). Moreover, RNA of BTV-4 was found in red deer blood samples in summer 192 
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2007, eight months after the last detection in sympatric domestic ruminants (Rodríguez-193 
Sánchez et al., 2010). Finally, our results indicate that red deer can maintain BTV RNA 194 
in blood for long periods, and therefore red deer have the potential to play a role in BT 195 
epidemiology. However, the lack of BTV isolation at 78 dpi suggests that only BTV 196 
RNA but no viable virus stays detectable long after the peak viraemia. Moreover, it 197 
remains unanswered whether the Culicoides vector can get infected from red deer. 198 
Nevertheless, the detection of BTV in skin samples of our experimentally-infected red 199 
deer at 14 dpi seems to point that it could be infectious to midges, at least during the 200 
peak of BTV RNA detection. 201 
 202 
6. Conclusion 203 
 204 
Red deer have the potential to be a reservoir for BT. A natural experiment to test 205 
this hypothesis is currently running: livestock has largely been vaccinated (European 206 
Commission, 2009), but annual re-vaccination is unlikely to be maintained for long. 207 
Vaccine induced immunity against BTV can last for over one year, but it may be lost 208 
after a certain time if no annual boost occurs (Hamers et al., 2009). Also, positive 209 
results of the vaccination campaigns rely on a minimum coverage of 80% of the 210 
susceptible population (Ferrari et al., 2005), and susceptible unvaccinated red deer could 211 
affect this minimum required goal. Hence, if repeated BTV outbreaks occur in regions 212 
with high wild ruminant densities and no clear link with livestock movements or 213 
vaccination failures, the deer reservoir hypothesis will be confirmed. If, in contrast, no 214 
BTV circulation takes place and livestock vaccination alone is successful in eradicating 215 
bluetongue, the hypothesis will be rejected. 216 
 217 
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Figure captions  353 
 354 
Figure 1.- Viral load (Ct=Cycle at which specific amplification starts to be detectable in 355 
the real-time RT-PCR technique) determined by generic BTV RRT-PCR on whole 356 
blood samples from 0 dpi to the end of the experiment (98-112 dpi). Serotype was 357 
confirmed by serotype-specific RRT-PCRs of the serotype inoculated in randomly 358 
selected samples for each deer. Upper panel: BTV1; Central panel: BTV8; Lower panel: 359 
control.  360 
 361 
Figure 2.- Kinetics of the BTV-neutralizing antibody response measured by VNT in 362 
BTV-inoculated and control red deer. Upper panel: sera from BTV-1 inoculated deer 1-363 
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4 and control deer 9 and 11 tested against BTV-1. Lower panel: sera from BTV-8 364 
inoculated deer 5-8 and control deer 10 and 11, tested against BTV-8. 365 
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FIGURE 1 
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FIGURE 2 
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